Milan, Italy

Giuseppe Meroni



Average Co-Inventor Count = 7.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2019

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Giuseppe Meroni: A Pioneer in Cancer Research

Introduction

Giuseppe Meroni is a notable inventor based in Milan, Italy. With a strong focus on pharmaceutical innovations, he has made significant contributions to the field of cancer research. With a total of three patents to his name, Meroni's work has the potential to greatly impact the treatment of various diseases.

Latest Patents

Giuseppe Meroni's latest patents include innovative compounds that serve as histone demethylase inhibitors. His first patent introduces cyclopropylamine compounds, described by a general formula (I), which are used in pharmaceutical compositions for therapeutic applications. These compounds are relevant for their potential uses in treating various health conditions.

The second patent focuses on thienopyrrole derivatives, detailed in Formulas (I) and (Ia). This invention offers pharmaceutical compositions that can inhibit KDM1, aiming to prevent and treat cancer, infectious diseases, and conditions related to abnormalities in cellular energy metabolism, such as obesity.

Career Highlights

Currently, Giuseppe Meroni is associated with Istituto Europeo di Oncologia S.r.l., where he engages in groundbreaking research and development. His work has been instrumental in advancing medical science, particularly in innovative cancer therapies. The significance of his patents illustrates his commitment to improving healthcare outcomes.

Collaborations

Throughout his career, Meroni has collaborated with esteemed colleagues, including Paola Vianello and Mario Varasi. These partnerships have enabled him to enrich his research and enhance the impact of his innovations in the pharmaceutical realm.

Conclusion

Giuseppe Meroni's inventive contributions are paving the way for new therapeutic approaches in the medical field. His focus on histone demethylase inhibitors highlights his dedication to addressing critical health challenges. As a leading figure in cancer research, Meroni continues to drive innovations that promise to benefit patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…